Literature DB >> 16741923

Rising prostate cancer rates in South Korea.

Sue Kyung Park1, Lori C Sakoda, Daehee Kang, Anand P Chokkalingam, Eunsik Lee, Hai-Rim Shin, Yoon-Ok Ahn, Myung-Hee Shin, Choong-Won Lee, Duk-Hee Lee, Aaron Blair, Susan S Devesa, Ann W Hsing.   

Abstract

BACKGROUND: Prostate cancer incidence and mortality rates in South Korea are relatively low, but rising steadily.
METHODS: We examined age-standardized incidence and mortality trends of prostate cancer in South Korea to gain further insight into prostate cancer etiology.
RESULTS: Although prostate cancer incidence has been low (7.9 per 100,000 man-years), it has increased up to 28.2% between 1996-1998 and 1999-2001. Prostate cancer mortality increased 12.7-fold over a 20-year period. Despite the increase in prostate cancer incidence and mortality rates, marked differences in rates remain for Koreans, Korean Americans, and Caucasian Americans.
CONCLUSIONS: The rising rates of prostate cancer in South Korea cannot be attributed entirely to PSA screening due to the low PSA screening prevalence; this trend is most likely related to increased westernization among Koreans. Interdisciplinary epidemiological studies incorporating the collection of biological samples are needed to clarify the extent to which lifestyle and genetic factors contribute to the observed racial disparity. Published 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741923     DOI: 10.1002/pros.20419

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  50 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

Review 2.  Opposing roles of folate in prostate cancer.

Authors:  Kevin J Rycyna; Dean J Bacich; Denise S O'Keefe
Journal:  Urology       Date:  2013-08-28       Impact factor: 2.649

3.  Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells.

Authors:  Sung-Lyul Lim; Sang-Yoon Park; Sukmin Kang; Dain Park; Sung-Hoon Kim; Jae-Young Um; Hyeung-Jin Jang; Jun-Hee Lee; Chul-Ho Jeong; Jung-Hee Jang; Kwang Seok Ahn; Seok-Geun Lee
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  The association between KL polymorphism and prostate cancer risk in Korean patients.

Authors:  Hae Jong Kim; Jaehyouk Lee; Shin Young Lee; Hyun Sub Cheong; Young-Sik Kye; Wonyong Kim; Seok-Soo Byun; Soon Chul Myung
Journal:  Mol Biol Rep       Date:  2014-08-14       Impact factor: 2.316

5.  Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells.

Authors:  Sukmin Kang; Eun-Ok Kim; Sung-Hoon Kim; Jun-Hee Lee; Kwang Seok Ahn; Miyong Yun; Seok-Geun Lee
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

6.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

7.  The 5-year functional outcomes after radical prostatectomy: a real-life experience in Korea.

Authors:  Sung Kyu Hong; Seung Hwan Doo; Dae Sung Kim; Won Ki Lee; Hong Zoo Park; Ji Hyun Park; Seong Jin Jeong; Cheol Yong Yoon; Seok-Soo Byun; Sang Eun Lee
Journal:  Asian J Androl       Date:  2010-09-13       Impact factor: 3.285

8.  The change of prostate cancer treatment in Korea: 5 year analysis of a single institution.

Authors:  Dong Hoon Lee; Ha Bum Jung; Mun Su Chung; Seung Hwan Lee; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

9.  Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Authors:  Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

10.  Docetaxel chemotherapy of Korean patients with hormone- refractory prostate cancer:comparative analysis between 1st-line and 2nd-line docetaxel.

Authors:  Jae Young Joung; In Gab Jeong; Kyung Seok Han; Taek Sang Kim; Seung Ok Yang; Ho Kyung Seo; Jinsoo Chung; Kang Su Cho; Kang Hyun Lee
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.